Andreas Katopodis

Co-Founder & CEO at Anaveon

Andreas Katopodis is the co-founder and CEO of Anaveon, a biotech company focused on developing treatments for autoimmune diseases. Prior to founding Anaveon, they were a director at Novartis Institutes of Biomedical Research.

Some direct reports include Christoph Huber - Chief Scientific Officer, Christine Wurz - Senior Quality Assurance Director, and Arkadi Khait - Head of Finance.

Location

Basel-City, Switzerland

Links


Org chart

Sign up to view 6 direct reports

Get started



Offices

This person is not in any offices